StockData
Vireo Growth Inc. logo

Vireo Growth Inc. (VREOF) stock

VREOFOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 11/30
$9.01+0.01 (+0.11%)

Close on Oct 19, 2026Market cap $443.48MP/E –Yield –

Vireo Growth cash

Cash and short-term investments held at the end of each period.

Vireo Growth's cash was $88.80M at Sep 30, 2026. For fiscal 2025 it was $103.20M, up 12.7% from the year before. The highest annual figure on record is $103.20M in fiscal 2025.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$103.20M+12.7%
FY2024Dec 31, 2024$91.60M+473.8%
FY2023Dec 31, 2023$15.96M+5.4%
FY2022Dec 31, 2022$15.15M-0.0%
FY2021Dec 31, 2021$15.16M-44.1%
FY2020Dec 31, 2020$27.11M+193.5%
FY2019Dec 31, 2019$9.23M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$88.80M-25.1%
Q2 FY2026Jun 30, 2026$104.10M-2.8%
Q1 FY2026Mar 31, 2026$123.40M+43.2%
Q4 FY2025Dec 31, 2025$103.20M+12.7%
Q3 FY2025Sep 30, 2025$118.51M+1527.9%
Q2 FY2025Jun 30, 2025$107.10M+853.8%
Q1 FY2025Mar 31, 2025$86.20M+583.9%
Q4 FY2024Dec 31, 2024$91.60M+473.8%
Q3 FY2024Sep 30, 2024$7.28M-45.2%
Q2 FY2024Jun 30, 2024$11.23M-1.0%
Q1 FY2024Mar 31, 2024$12.60M+21.8%
Q4 FY2023Dec 31, 2023$15.96M+5.4%
Q3 FY2023Sep 30, 2023$13.30M-39.1%
Q2 FY2023Jun 30, 2023$11.35M-33.1%
Q1 FY2023Mar 31, 2023$10.35M+20.3%
Q4 FY2022Dec 31, 2022$15.15M-0.0%
Q3 FY2022Sep 30, 2022$21.84M+85.4%
Q2 FY2022Jun 30, 2022$16.97M-18.5%
Q1 FY2022Mar 31, 2022$8.60M-78.8%
Q4 FY2021Dec 31, 2021$15.16M-44.1%
Q3 FY2021Sep 30, 2021$11.78M-34.1%
Q2 FY2021Jun 30, 2021$20.83M+184.5%
Q1 FY2021Mar 31, 2021$40.56M+245.8%
Q4 FY2020Dec 31, 2020$27.11M+193.5%
Q3 FY2020Sep 30, 2020$17.87M–
Q2 FY2020Jun 30, 2020$7.32M–
Q1 FY2020Mar 31, 2020$11.73M–
Q4 FY2019Dec 31, 2019$9.23M–

More Vireo Growth figures

See a number that looks wrong?